Wang Tisha S, Deng Jane C
Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
J Mol Med (Berl). 2008 May;86(5):495-506. doi: 10.1007/s00109-007-0300-4. Epub 2008 Feb 8.
Sepsis is a significant cause of death worldwide. Although the prevailing theory of the sepsis syndrome has been that of a condition of uncontrolled inflammation in response to infection, sepsis is increasingly being recognized as an immunosuppressive state. The immune modulations of sepsis result in altered innate and adaptive immune responses, thereby rendering the septic host susceptible to secondary infections. In this review, we present an overview of the clinical and experimental evidence for sepsis-induced immunosuppression and outline the mechanisms that underlie this phenotype. With an improved understanding of how host immune states may be altered during sepsis, better immunomodulatory therapies may be developed to address the immune derangements observed in patients with sepsis.
脓毒症是全球范围内的一个重要死亡原因。尽管目前关于脓毒症综合征的主流理论认为它是一种对感染产生的不受控制的炎症状态,但脓毒症越来越被认为是一种免疫抑制状态。脓毒症的免疫调节导致先天性和适应性免疫反应发生改变,从而使脓毒症宿主易患继发性感染。在本综述中,我们概述了脓毒症诱导免疫抑制的临床和实验证据,并概述了这种表型背后的机制。随着对脓毒症期间宿主免疫状态如何改变的进一步了解,可能会开发出更好的免疫调节疗法来应对脓毒症患者中观察到的免疫紊乱。